Ignite Creation Date:
2024-05-06 @ 12:55 PM
Last Modification Date:
2024-10-26 @ 1:06 PM
Study NCT ID:
NCT03881722
Status:
COMPLETED
Last Update Posted:
2019-03-19
First Post:
2018-02-17
Brief Title:
Effect of Magnesium Alginate in Infants With Gastroesophageal Reflux
Sponsor:
Policlinico Hospital
Organization:
Policlinico Hospital
Study Overview
Official Title:
Effect of Magnesium Alginate in Infants With Gastroesophageal Reflux
Status:
COMPLETED
Status Verified Date:
2019-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Recurrent regurgitation stress the infants and their parents and often results in an inappropirate use of PPI prescription in infancy The aim of this study is to evaluate the efficacy of Mg alginate in infants with symptoms of gastroesophageal reflux
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None